About: covid:arg/0fef31327679a434620a4bd182764591a31ac502/1   Goto Sponge  NotDistinct  Permalink

An Entity of Type : amo:Evidence, within Data Space : wasabi.inria.fr associated with source document(s)

AttributesValues
type
wasQuotedFrom
sioca:supports
aif:formDescription
  • Low - dose subcutaneous tocilizumab TCZ ( 324 mg ) was associated with a rapid and significant reduction in C reactive protein ( CRP ) paralleled by a progressive improvement in oxygenation as reflected by the ratio of partial pressure of oxygen to fraction of inspired oxygen ( P / F ) ratio .
proves
is hasSource of
is sioca:supports of
is has evidence of
is proves of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software